Franklin Biolabs Emerges as a Leader in Genetic Medicines
Franklin Biolabs has recently begun operations, marking a significant milestone in the field of genetic medicines. This new contract research organization (CRO) is dedicated to offering industry-leading services that bridge the gap between groundbreaking research and the practical application of gene therapies. Founded by esteemed gene therapy expert Dr. James Wilson, Franklin Biolabs is already delivering comprehensive solutions tailored for the global genetic medicines market.
Comprehensive Services Offered
The organization operates with a team of over 130 skilled professionals who specialize in a variety of crucial services. These include immunology, vector production and analytics, as well as next-generation sequencing and bioinformatics. In addition, the CRO conducts nonclinical pharmacology and toxicology studies, ensuring that clients receive thorough and detailed insights throughout the development process.
A Commitment to Innovation
Franklin Biolabs is more than just a service provider; it is positioned as a pioneer committed to revolutionizing the genetic medicines sector. The company’s roots pay homage to American inventor Ben Franklin, symbolizing a spirit of innovation and exploration. With a mission to support the development of novel therapies for a range of severe disorders, Franklin Biolabs is primed to make a substantial impact in the healthcare industry.
Backing from Industry Leaders
The establishment of Franklin Biolabs has been significantly bolstered by strategic investment from Savanne Life Sciences. This partnership not only provides financial support but also brings invaluable expertise in the biotechnology landscape. Together, they are poised to advance genetic medicine development, making treatments for severe and debilitating conditions more accessible to patients around the globe.
Shared Vision for Transformation
Dr. Wilson expressed gratitude towards the Savanne team, emphasizing their mutual goal of driving transformative theories into actionable treatments. The collaboration aims to harness a broad spectrum of resources and knowledge that can catalyze the delivery of innovative therapies. This partnership is significant, as it underscores a shared commitment to reshaping the global genetic medicines industry.
About Franklin Biolabs
Franklin Biolabs is redefining the CRO landscape with its comprehensive approach to genetic medicine services. With decades of collective experience, the team focuses on translating rigorous scientific research into impactful clinical trials. By providing specialty services across multiple areas, the company is well-equipped to meet the escalating demands of modern medical research and patient care.
Leadership Driving Change
Under the leadership of Dr. James Wilson, who also serves as the President and CEO of GEMMABio, Franklin Biolabs aims to deliver effective gene therapies that cater to patient needs. The organization's vision includes translating innovative concepts into successful clinical applications, ensuring a robust pipeline of transformative medications reaches those in need.
Contact Information
For more inquiries, Scott Hoeflich can be reached via email at shoeflich@briancom.com. This open line of communication underscores Franklin Biolabs' commitment to collaboration and transparency as they embark on this ambitious journey to reshape the gene therapy paradigm.
Frequently Asked Questions
What services does Franklin Biolabs offer?
Franklin Biolabs offers a variety of services including immunology, vector production, next-generation sequencing, and pharmacology studies.
Who founded Franklin Biolabs?
Franklin Biolabs was founded by Dr. James Wilson, an accomplished expert in gene therapy.
What is the mission of Franklin Biolabs?
The mission is to advance the development of genetic medicines for severe disorders and deliver transformative therapies to patients.
How does Franklin Biolabs support research?
Franklin Biolabs provides critical research services to biotech companies and academic institutions, aiding in the clinical development of new therapies.
Who is backing Franklin Biolabs?
Franklin Biolabs is backed by Savanne Life Sciences, which provides strategic investment and expertise in biotechnology.
